EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:189866 |
| ChEBI Name | PPDA |
| Stars | |
| Definition | A racemate comprising equimolar amounts of (2R,3S)- and (2S,3R)-PPDA. It is a subtype-selective NMDA receptor antagonist that preferentially binds to GluN2C/GluN2D (formally NR2C/NR2D) containing receptors. |
| Last Modified | 11 May 2022 |
| Submitter | slaulederkind |
| Formula | C21H18N2O5 |
| Net Charge | 0 |
| Average Mass | 378.384 |
| Monoisotopic Mass | 378.12157 |
| Roles Classification |
|---|
| Biological Role: | NMDA receptor antagonist Any substance that inhibits the action of N-methyl-D-aspartate (NMDA) receptors. They tend to induce a state known as dissociative anesthesia, marked by catalepsy, amnesia, and analgesia, while side effects can include hallucinations, nightmares, and confusion. Due to their psychotomimetic effects, many NMDA receptor antagonists are used as recreational drugs. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| PPDA (CHEBI:189866) has part (2R,3S)-PPDA (CHEBI:189871) |
| PPDA (CHEBI:189866) has part (2S,3R)-PPDA (CHEBI:189872) |
| PPDA (CHEBI:189866) has role NMDA receptor antagonist (CHEBI:60643) |
| PPDA (CHEBI:189866) is a racemate (CHEBI:60911) |
| IUPAC Name |
|---|
| rac-(2R,3S)-1-(phenanthren-2-ylcarbonyl)piperazine-2,3-dicarboxylic acid |
| Synonyms | Source |
|---|---|
| cis-PPDA | SUBMITTER |
| cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid | ChEBI |
| (2S*,3R*)-1-(phenanthren-2-carbonyl)piperazine-2,3-dicarboxylic acid | ChEBI |
| Registry Numbers | Sources |
|---|---|
| CAS:684283-16-7 | ChEBI |
| Citations |
|---|